The relaxation effect and mechanism of action of higenamine in the rat corpus cavernosum

International Journal of Impotence Research

Volumn 24, Issue 2, 2012, Pages 77-83

  Kam, S C ^a   Do, J M ^a   Choi, J H ^a   Jeon, B T ^a   Roh, G S ^a   Chang, K C ^a   Hyun, J S ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

Author keywords

corpus cavernosum; erection; higenamine

Indexed keywords

4 AMINOPYRIDINE; CYCLIC GMP; GLIBENCLAMIDE; HIGENAMINE; INDOMETACIN; METHYLENE BLUE; PHOSPHODIESTERASE INHIBITOR; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DOSE RESPONSE; DRUG MECHANISM; ERECTILE DYSFUNCTION; MALE; MUSCLE RELAXATION; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; RAT;

ADRENERGIC BETA-AGONISTS; ALKALOIDS; ANIMALS; AORTA; CYCLIC AMP; CYCLIC GMP; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; ERECTILE DYSFUNCTION; MALE; PENIS; PHOSPHODIESTERASE 5 INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; TETRAHYDROISOQUINOLINES;

EID: 84858701054     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2011.48     Document Type: Article

References (34)

1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61. (Pubitemid 24046934)
2. Fagelman E, Fagelman A, Shabsigh R. Efficacy, safety, and use of sildenafil in urologic practice. Urology 2001; 57: 1141-1144. (Pubitemid 32455588)
3. McMahon CN, Smith CJ, Shabsigh R. Treating erectile dysfunction when PDE5 inhibitors fail. BMJ 2006; 332: 589-592. (Pubitemid 44365759)
4. Gholamine B, Shafiei M, Motevallian M, Mahmoudian M. Effects of pioglitazone on erectile dysfunction in sildenafil poor-responders: A randomized, controlled study. J Pharm Sci 2008; 11: 22-31.
5. Kosuge T, Yokota M, Nagasawa M. Studies on cardiac principle in Aconite roots. I. Isolation and structural determination of higenamine (author's transl). Yakugaku Zasshi 1978; 98: 1370-1375. (Pubitemid 9072484)
6. Park CW, Chang KC, Lim JK. Effects of higenamine on isolated heart adrenoceptor of rabbit. Arch Int Pharmacodyn Ther 1984; 267: 279-288. (Pubitemid 14195400)
7. Bai G, Yang Y, Shi Q, Liu Z, Zhang Q, Zhu YY. Identification of higenamine in Radix Aconiti Lateralis Preparata as a beta2- adrenergic receptor agonist1. Acta Pharmacol Sin 2008; 29: 1187-1194.
8. Wong KK, Lo CF, Chen CM. Endothelium-dependent higenamine- induced aortic relaxation in isolated rat aorta. Planta Med 1997; 63: 130-132. (Pubitemid 27196079)
9. Yun-Choi HS, Pyo MK, Park KM, Chang KC, Lee DH. Antithrombotic effects of YS-49 and YS-51-1-naphthylmethyl analogs of higenamine. Thromb Res 2001; 104: 249-255. (Pubitemid 33145209)
10. Yun-Choi HS, Pyo MK, Park KM, Chang KC, Lee DH. Antithrombotic effects of higenamine. Planta Med 2001; 67: 619-622.
11. Lee YS, Kang YJ, Kim HJ, Park MK, Seo HG, Lee JH et al. Higenamine reduces apoptotic cell death by induction of heme oxygenase-1 in rat myocardial ischemia-reperfusion injury. Apoptosis 2006; 11: 1091-1100. (Pubitemid 44035958)
12. BagciVan I, Gokce G, Yildirim S, Sarioglu Y. Investigation of the mechanism of nicotine induced relaxation in rabbit corpus cavernosum in vitro. Urol Res 2004; 32: 209-212. (Pubitemid 38915689)
13. Utkan NZ, Utkan T, Sarioglu Y, Cantü rk NZ, Okay E. Investigation of the mechanism of nicotine-induced relaxation in guinea pig gallbladder. J Surg Res 2003; 110: 272-275. (Pubitemid 36403718)
14. Skiker M, Mekhfi H, Aziz M, Haloui B, Lahlou S, Legssyer A et al. Artemisia herba-alba Asso relaxes the rat aorta through activation of NO/cGMP pathway and K(ATP) channels. J Smooth Muscle Res 2010; 46: 165-174.
15. Diederichs W, Stief CG, Lue TF, Tanagho EA. Norepinephrine involvement in penile detumescence. J Urol 1990; 143: 1264-1266. (Pubitemid 20193103)
16. Chang KC, Lim JK, Park CW. Synthesis of higenamine and its cardiovascular effects in rabbit: Evidence for b-adrenoceptor agonist. Kor J Pharmacol 1986; 22: 96-104. (Pubitemid 17022942)
17. Yun-Choi HS, Pyo MK, Chang KC, Lee DH. The effects of higenamine on LPS-induced experimental disseminated intravascular coagulation (DIC) in rats. Planta Med 2002; 68: 326-329.
18. Costa P, Soulie-Vassal ML, Sarrazin B, Rebillard X, Navratil H, Bali JP. Adrenergic receptors on smooth muscle cells isolated from human penile corpus cavernosum. J Urol 1993; 150: 859-863. (Pubitemid 23241284)
19. Hedlund H, Andersson KE. Comparison of the responses to drugs acting on adrenoreceptors and muscarinic receptors in human isolated corpus cavernosum and cavernous artery. J Auton Pharmacol 1985; 5: 81-88. (Pubitemid 15117235)
20. Recio P, Lopez PG, Fernandez JL, Garcia-Sacristan A. Pharmacological characterization of adrenoceptors in horse corpus cavernosum penis. J Auton Pharmacol 1997; 17: 191-198. (Pubitemid 27331475)
21. Andersson KE, Hedlund P, Alm P. Sympathetic pathways and adrenergic innervation of the penis. Int J Impot Res 2000; 12(Suppl 1): S5-S12. (Pubitemid 30255741)
22. Carati CJ, Goldie RG, Warton A, Henry PJ, Keogh EJ. Pharmacology of the erectile tissue of the canine penis. Pharmacol Res Commun 1985; 17: 951-966. (Pubitemid 16235198)
23. Cirino G, Sorrentino R, di Villa Bianca R, Popolo A, Palmieri A, Imbimbo C et al. Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function. Proc Natl Acad Sci USA 2003; 100: 5531-5536. (Pubitemid 36542739)
24. Teixeira CE, Baracat JS, Zanesco A, Antunes E, De Nucci G. Atypical beta-adrenoceptor subtypes mediate relaxations of rabbit corpus cavernosum. J Pharmacol Exp Ther 2004; 309: 587-593. (Pubitemid 38542611)
25. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995; 75: 191-236.
26. Sáenz de Tejada I, Angulo J, Cellek S, González-Cadavid N, Heaton J, Pickard R et al. Physiology of erectile function. J Sex Med 2004; 1: 254-265. (Pubitemid 40424634)
27. Lue TF. Erectile dysfunction. N Engl J Med 2000; 342: 1802-1813. (Pubitemid 30390241)
28. Christ GJ, Lue T. Physiology and biochemistry of erections. Endocrine 2004; 23: 93-100. (Pubitemid 39140218)
29. Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, Naylor AM. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 1998; 159: 2164-2171. (Pubitemid 29190800)
30. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397-1404. (Pubitemid 28221980)
31. Wespes E, Rammal A, Garbar C. Sildenafil non-responders: haemodynamic and morphometric studies. Eur Urol 2005; 48: 136-139; discussion 139. (Pubitemid 40835609)
32. Al-Shaiji TF, Brock GB. Phosphodiesterase type 5 inhibitors for the management of erectile dysfunction: Preference and adherence to treatment. Curr Pharm Des 2009; 15: 3486-3495.
33. Chang KC, Chong WS, Lee IJ. Different pharmacological characteristics of structurally similar benzylisoquinoline analogs, papaverine, higenamine, and GS 389, on isolated rat aorta and heart. Can J Physiol Pharmacol 1994; 72: 327-334. (Pubitemid 24215278)
34. Kim NN, Huang Y, Moreland RB, Kwak SS, Goldstein I, Traish A. Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells. Mol Cell Biol Res Commun 2000; 4: 10-14.